The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

A grand jury in New York has indicted Luigi Mangione, 26, on 11 charges, including murder in the first degree. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

The Patients Before Monopolies Act, introduced in both the House and Senate, gives parent companies of PBMs three years to divest from pharmacies or face penalties. 

Bottles of duloxetine manufactured by Rising Pharmaceuticals are being recalled due to higher-than-normal levels of nitrosamine contaminants. The recall is classified as Class II, the second most serious type.

The Federal Trade Commission did not accuse the companies of wrongdoing. However, it advised them to stay out of trouble by not deploying robocalls, impersonating the government or other common illegal marketing strategies. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty. 

FDA Commissioner Robert Califf, MD, talked to Cardiovascular Business about healthcare spending, inconsistent patient outcomes and much more.